Semaglutide(Qilu Pharmaceutical)

司美格鲁肽（齐鲁制药）

Report date: 2025/11/07 14:52:38

Base Information

Drug NameSemaglutide(Qilu Pharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightBody WeightObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A